Drugs · Entity Annotation Prototype (beta)

3articles mentioning drugs

3drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Janus kinase inhibitor ×

Janus kinase inhibitor

This drug is selected. Its supporting articles are shown below.

Janus kinase inhibitor3

Articles mentioning Janus kinase inhibitor

3 articles · page 1 of 1

Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis

rmdopen · abstract · 2026-05-07 · 1 matching annotations

76.7%

b/tsDMARD tumour necrosis factor inhibitor Janus kinase inhibitor psoriatic arthritis ischaemic heart disease PsA diabetes European rheumatology registries hypertension dyslipidaemia

…ad higher disease activity at treatment initiation of the first b/tsDMARD. Prescription patterns varied with comorbidity burden. Cardiome…

PO:11:293 Efficacy and safety of BTK inhibitors in systemic lupus erythematous: a systematic review and meta-analysis

lupusscimed · abstract · 2026-03-01 · 1 matching annotations

90.2%

Janus kinase inhibitor SLE SLEMethods systemic lupus erythematous

…in only 1 RCT but was confounded with the coadministration of a Janus kinase inhibitor. This study was excluded from the meta-analysis. Adverse event …

STAT3 gain-of-function mutation presenting with adult-onset recurrent abdominal pain, fever and lymphadenopathy, managed by JAK inhibitor therapy

bmjcr · abstract · 2026-01-19 · 1 matching annotations

89.3%

tofacitinib Janus kinase inhibitor Targeted therapy

…n the STAT3 gene. Targeted therapy with Janus kinase inhibitor (tofacitinib) led to significant clinical and radiological improvement. This…